premium content
Levrett: Prospectus released - good news for the (founder) shareholders: is this the new Cloudtag?
At the start of the month, I asked the question on the lips of all the Levrett (LVRT) shareholders, namely when the bloody RTO was finally going to arrive. Well, fair play, it was announced on Friday and shareholders should be pleased, particularly the founders who got in at a fraction of the price of the ordinary private investor.
- By Cynical Bear |
- 17 September 2017, 03:44 |
Notes from Underground - Pay to play
We're four days into the reader supported ShareProphets and I'd rate it a stunning success. But what lessons are to be learnt are less clear.
- By Pizza Hardman Darren Atwater |
- 17 September 2017, 03:44 |
premium content
Tom Winnifrith Bearcast - IQE the valuation must be insane & interest rate rise ahoy!
It is my son's first birthday today - how time flies! I start with a look at inflation. It is back! And the greed of the lazy public sector workers (demonstrated clearly HERE) will fuel it which means interest rate rises ahoy. I suggest this has clear implications you should not ignore. Then I take a detailed look at IQE (IQE),its last results,investor perceptions and explain why I believe that the shares at 131p are a very poor risk reward play for the bulls like Comrade Stacey.
- By Tom Winnifrith |
- 16 September 2017, 01:58 |
Alliance Pharma – despite Diclectin disappointment, still looking good, BUY
Speciality pharmaceutical company Alliance Pharma (APH) has announced results for the first half of 2017 and that “having delivered results in this period in line with expectations, and having a sound platform in place, we look forward to the second half and beyond with confidence" I agree and this offers a way to get a good solid low risk 15% return. Let me explain.
- By Steve Moore |
- 16 September 2017, 00:39 |
CyanConnode – another set of results, ANOTHER placing!
CyanConnode (CYAN) has announced results for the first half of 2017, including “we are delighted with the progress made during the period”. Good, good. Oh what? Already down from above 0.20p at the start of the year, the shares further lower at 0.16p? Hmmm…
- By Steve Moore |
- 16 September 2017, 00:39 |
Bitcoin is Going to Drive Gold & Silver to All Time Highs
I still really do not understant bitcoin but it seems to grip fellow libertarians like Dominic Frisby and, in this case, resource guru Doug Casey. In this Palisade Capital podcast, Doug discusses the commodity markets and why the most important thing is what they do cyclically. Most commodities are down 50% since 2011 and the dollar has lost 20%. Commodities remain quite cheap, particularly gold, silver, and copper. He discusses Junior miners and why now is a good time to get into these markets.
- By Tom Winnifrith |
- 16 September 2017, 00:38 |
Table of shorted AIM shares - week to 15/09/2017
From the FCA's spreadsheet of short positions required to be disclosed to it, the following shows the shorted AIM shares with positions from 2016 and thus far in 2017 (by net short position %) - and if this position has increased (red), reduced (green) or remained unchanged (black) since last week...
- By Steve Moore |
- 16 September 2017, 00:38 |
premium content
A man who celebrates making money on the stockmarket thanks to Parsons Green - scumbag H Khan
Mr H Khan appears not to realise that tweeting out boasts about how his FTSE short paid out thanks to London, i.e.the terrorist attack at Parsons Green, is more than a bit tasteless. I tweeted a suitable reply as you can see below.
- By Tom Winnifrith |
- 16 September 2017, 00:38 |
Wishbone Gold – interims, Honduras disruption but potential African excitement: BUY
Wishbone Gold (WSBN) has announced results for the first half of 2017, including an update on the initial funding-and-supply roll-out in Honduras and that “discussions are currently underway with two African nations to set up similar programs”…
- By HotStockRockets |
- 16 September 2017, 00:37 |
premium content
With IQE and Similar Rockets to the Stars, Follow this Simple Strategy.
Hello Share Markers. The fact that you now have to pay £6 a month to read my modest articles, means that some of my regulars are no longer with us. Trouble is they lose out on all the other learned articles - including the dire warnings - and that could cost them thousands of pounds. Still, nearly every one on this planet is penny wise and pound foolish. And I don’t like paying for internet content either. It’s just that investing in shares is too dodgy not to have the best independent advice going.
premium content
Hugh Hendry calls it a day saying the market has got it wrong
Hugh Hendry was one of the funniest and articulate of fund managers and for a while his Eclectica funds delivered - as bears - spectacular returns. But Mr Market went against him and he has now closed up shop with his main fund worth a meagre $30.6 million. His final parting shot is a letter in which he has given up on fighting fake news. Over to the great man
- By Tom Winnifrith |
- 15 September 2017, 07:36 |
premium content
Tom Winnifrith Bearcast: Blenheim & Allied Minds, why is Neil Woodford backing only 1 of these 2 accidents waiting to happen
In today's bearcast I take a detailed look at Allied Minds (ALM) another Woodford disaster waiting to happen and then at 60% overvalued Blenheim Natural Resources (BNR). I comment on accident prone DX Group (DX.) before asking where's Debbie gone? Yes has the Milestone (MSG) boss been resigned already?
- By Tom Winnifrith |
- 15 September 2017, 07:00 |
Tungsten Corp – AGM update, EBITDA breakeven ‘remains goal’. Who’s paying for the capex? The tooth fairy?
Shares in Tungsten Corp (TUNG) are currently edging higher, above 60p, on the back of an AGM trading update – this though comparing to above 70p as recently as June and approaching 400p in 2014…
- By Steve Moore |
- 15 September 2017, 04:07 |
premium content
AIM Listed Applied Graphene and the BIG LIE exposed: BTW it is Placing ahoy
Companies that tell lies to investors are ones that should be avoided like the plague. If you pick a company up on one lie the odds are that there are stacks of others going undetected. That brings me to Applied Graphene Materials (AGM) where I will demonstrate a slam dunk lie. Then we will turn to its looming cash crisis.
- By Tom Winnifrith, The Sheriff of AIM |
- 15 September 2017, 03:50 |
premium content
Advanced Oncotherapy – is a family member of boss Dr Mike Sinclair worth £269,265?
Shares in AIM-listed Advanced Oncotherapy (AVO) are still languishing well below the par price of 25p and the company must surely by now be running pretty low on cash. But a look at the FY16 accounts throws up some interesting questions over remuneration.
- By Nigel Somerville, the Deputy Sheriff of AIM |
- 15 September 2017, 02:24 |
Buy Falanx at a 7.5p offer - target to sell 10p+
First the disclosures. No 1. We own stacks of these shares (bought at 4p) but will not sell until the shares are north of 10p. No 2. Hotstockrockets tipped them at a 4.25p offer and has them as a STRONG HOLD -I think certain colleagues are too cautious. Now over to cybersecurity play Falanx (FLX) which has recently served up a cracking trading statement and a cute little acquisition. Falanx says that in the run up to its half year end (30 September) it has won "significant new sales contracts with recurring revenue... Remains on course for operational breakeven this financial year." It repeats that "business on track to reach breakeven during the financial year with sufficient cash to see all current operations through to profitability."
- By Tom Winnifrith |
- 15 September 2017, 02:04 |
premium content
Fun and Games, Brotherly love at Cantor Fitzgerald, Unicorn and Directa Plus
Graphite play Directa Plus (DCTA) was not one of the better new issues of 2016. Nomad and broker Cantor Fitzerald earned a good few shekels raising it £12.8 million at 75p in May 2016. The shares roofed it to 200p but the crashed to 32p by early August this year. At that point Cantor's decided to earn its shekels as retained broker with analyst William Game (pictured below) upgrading his stance from corporate "hold" to "buy". Paid for rampers Proactive reports:
- By Tom Winnifrith |
- 15 September 2017, 01:57 |
Eve Sleep: Interims out – decent execution but the jury’s still out for me
I covered the trading update for the Woodford-backed Eve Sleep (EVE) HERE but with interims out this week, it is worth taking a closer look to assess progress in its maiden year on AIM. In summary, I would give it a B+ grade for execution but only a D grade for “ability to show there is a viable business model here” and would keep a watching brief for now. Doesn’t stop Neil Woodford getting stuck In some more though – natch
- By Cynical Bear |
- 15 September 2017, 01:44 |
premium content
Buy Columbus Energy as a ten bagger says Andrew Monk (with charts)... and ANO Total loon
In his private email to clients this morning Andrew Monk of VSA, broker to Columbus (CERP) brings charts from yesterday's AGM presentation and uses them to explain why he sees the shares, he first tipped at sub 2p, roofing it. He is not the only fan...but first to Monkey who gushes:
- By Tom Winnifrith |
- 15 September 2017, 01:44 |
Monchhichi – More comedy from these jokers as it moves to the Sub-Standard List
I was smiling for much of yesterday having read the announcement from Monchhichi (MCC) about its proposed cancellation from AIM and a move to the Sub-Standard segment of the Main Market. Let me explain why.
- By Cynical Bear |
- 15 September 2017, 01:41 |